Warning: The NCBI web site requires JavaScript to function. more...
An official website of the United States government
The .gov means it's official. Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you're on a federal government site.
The site is secure. The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.
EGLN3 - Clear cell renal cell carcinoma (HB-U133B)
GEO DataSets Gene Profile neighbors Chromosome neighbors Homologene neighbors
EGLN3 - HIV-1 Vpr effect on monocyte-derived macrophage
EGLN3 - Sunitinib effect on renal cancer xenograft tumors
EGLN3 - Normal tissues of diverse types (SHDP)
EGLN3 - Pretreatment breast needle biopsies of locally advanced breast cancer
EGLN3 - Clear-cell renal cell carcinoma tumors and tumorgrafts deficient for tumor suppressor BAP1 or PBRM1
EGLN3 - Epidermal growth factor effect on HER2-overexpressing mammary epithelial MCF10A cells: time course
EGLN3 - Early and late onset severe preeclampsia: placenta
EGLN3 - Peripheral blood monocyte response to Francisella tularensis infections
EGLN3 - Caseous tuberculosis granulomas comparison with normal lung parenchyma
Various cell lines and Universal Reference RNA (II)
EGLN3 - Pancreatic ductal adenocarcinoma tumor and adjacent non-tumor tissue
EGLN3 - c-MYC depletion effect on carcinoma cell lines
EGLN3 - Hypoxia effect on monocyte-derived, mature dendritic cells
EGLN3 - CD133-positive and CD133-negative colon cancer cells
EGLN3 - Skeletal myoblast cell line KM109 differentiation: time course (II, dye-swap)
EGLN3 - Renal clear cell carcinoma (HG-U133B)
Filters: Manage Filters
Your browsing activity is empty.
Activity recording is turned off.
Turn recording back on